27 results on '"Mira Didic"'
Search Results
2. P3‐368: PREDICTING AND MONITORING SHORT‐TERM DISEASE PROGRESSION IN A‐MCI PATIENTS WITH PRODROMAL AD USING MRI STRUCTURAL BRAIN BIOMARKERS
3. P4‐077: BLOOD INFLAMMATORY PROFILES MEASURED BY THE ADFLAG ® TEST ENABLE STRATIFICATION OF PRE‐DEMENTIA ALZHEIMER'S DISEASE
4. IC‐P‐126: VOLUMETRIC ACCURACY OF A FULLY AUTOMATIC TOOL FOR WHITE MATTER HYPERINTENSITIES (WMHS) SEGMENTATION
5. [P3–062]: ACROSS‐SESSION REPRODUCIBILITY OF AUTOMATIC WHITE MATTER HYPERINTENSITIES SEGMENTATION: A EUROPEAN MULTI‐SITE 3T STUDY
6. [P4–157]: CSF BIOMARKERS AND EFFECT OF APOLIPOPROTEIN E GENOTYPE, AGE AND SEX ON CUT‐OFF DERIVATION IN MILD COGNITIVE IMPAIRMENT
7. [IC‐P‐167]: ACROSS‐SESSION REPRODUCIBILITY OF AUTOMATIC WHITE MATTER HYPERINTENSITIES SEGMENTATION: A EUROPEAN MULTI‐SITE 3T STUDY
8. [P3–214]: ADFLAG ® , A DIAGNOSTIC BLOOD TEST FOR PRE‐DEMENTIA STAGES OF ALZHEIMER's DISEASE
9. P4‐122: Prevalence of Vascular Risk Factors in Different Stages of Prodromal Alzheimer’s Disease and Its Influence on Cognitive Decline
10. P2‐304: Deficits in Visual Recognition Memory: A Marker of Early Mesial Temporal Lobe Degeneration in Nondemented Outpatients from Memory Clinics?
11. P2‐302: CSF Beta‐Amyloid‐ and APOE Ɛ4‐Related Decline in Episodic Memory Over 12 Months Measured using the Cantab in Individuals with Amnestic MCI: Results from the European ADNI Study
12. P2‐188: Characterization of cognitive function with the cantab in individuals with amnestic mild cognitive impairment in relation to hippocampal volume, amyloid, and tau status: Preliminary baseline results from the PharmaCog/european‐ADNI study
13. IC‐04‐05: Multisite hippocampal subfields reproducibility: A european 3T study
14. IC‐P‐115: Longitudinal white matter alterations of MCI patients in WP5 PharmaCog/E‐ADNI study: Preliminary data
15. P3‐182: Hippocampal subfield changes in mild cognitive impairment patients with Alzheimer's disease pathology
16. IC‐P‐137: Longitudinal reproducibility of default‐mode network connectivity in healthy elderly participants: A multicentric resting‐state fMRI study
17. P3‐101: CROSS‐SECTIONAL BIOMARKER CHARACTERIZATION OF MILD COGNITIVE IMPAIRMENT PATIENTS IN WP5 PHARMACOG/E‐ADNI STUDY
18. IC‐P‐080: Cross‐sectional clinical, neuropsychological, neuroimaging, neurophysiological and biochemical characterization of people with mild cognitive impairment in the WP5 PharmaCog/E‐ADNI study
19. IC‐P‐044: Test‐retest reproducibility of brain morphometry, diffusion and resting‐state fMRI: A 3T consortium study
20. P3–121: Test‐retest reproducibility of brain morphometry, diffusion and resting‐state fMRI: A 3T consortium study
21. P1–151: Cross‐sectional clinical, neuropsychological, neuroimaging, neurophysiological and biochemical characterization of people with mild cognitive impairment in WP5 pharmacog/E‐ADNI study
22. O1‐07‐08: Resting brain metabolic connectivity in prodromal Alzheimer's disease: Evidence for early functional disconnection–An EADC joint project
23. O4‐05‐07: Subhippocampal dysfunction as a clinical marker of incipient Alzheimer's disease
24. P2–297: Heterogeneous atrophy of medial temporal lobe structures in patients with amnesic mild cognitive impairment
25. P2–346: Metabolic patterns in amnestic MCI patients assessed with MR spectroscopic imaging: Relationship with the type of memory impairment
26. P2–199: Grey matter loss in amnestic MCI according to the profile of memory impairment
27. IC–P–078: Brain SPECT patterns associated with different profiles of memory impairment in amnestic MCI
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.